Try our Advanced Search for more refined results
Competition
Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.
Sign up for a 7-day FREE trial today!
Latest News in Competition
-
November 06, 2025
Sinclair Says Disney-YouTube Blackout An Antitrust Problem
Sinclair's CEO expressed frustration about the ongoing blackout of Disney programming on YouTube TV, saying the dispute between media giants raises potential antitrust concerns because local broadcasters whose stations are affiliated with Disney's ABC broadcast network have no say over whether their content is getting distributed to viewers.
-
November 06, 2025
Sutter Health Patients' Attys To Get Over $100M Fees, Costs
A California U.S. magistrate judge said Thursday that she is ready to grant final approval of a $228.5 million deal settling a 13-year case over claims that Sutter Health boosted costs by pushing all-or-nothing networks on insurers, which includes $75.4 million in attorney fees and over $28 million in litigation expenses.
-
November 06, 2025
Ex-COO Says Yale New Haven Hospital Owes Him Nearly $1M
Yale New Haven Hospital owes its former chief operating officer more than $994,000 under a noncompete agreement that guarantees him regular payments, according to a Connecticut federal lawsuit claiming that the hospital is improperly withholding the money because he supposedly did not give enough notice of his resignation.
-
November 06, 2025
Game Not Over: Player Redshirt Suits Keep NCAA On Defense
A class action recently filed in Tennessee federal court highlights a trend of student-athlete challenges to the NCAA's four seasons eligibility rule following the historic House settlement in June, which altered revenue-sharing and players' name, image and likeness rights, say attorneys at BakerHostetler.
-
November 06, 2025
Edwards Defends $945M Heart Valve Deal From FTC Challenge
Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.
Areas of Coverage
- AGENCIES
- U.S. Department of Justice, Antitrust Division
- Federal Trade Commission, Bureau of Competition
- European Commission, Competition Directorate
- UK Competition and Markets Authority
- Germany’s Federal Cartel Office
- China’s Ministry Of Commerce
- Japan Fair Trade Commission
- Korea Fair Trade Commission
- Canada’s Competition Bureau
- Brazil’s Council for Economic Defense
- POLICY & REGULATION
- Clayton Act
- Federal Trade Commission Act
- Foreign Corrupt Practices Act
- Racketeer Influenced and Corrupt Organizations Act
- Robinson-Patman Act
- Sherman Act
- International antitrust legislation and regulation
- ENFORCEMENT
- Criminal charges over antitrust issues
- Global cartel investigations and actions
- Merger reviews and second requests
- Merger challenges and divestiture orders
- Anti-monopoly actions
- Pharmaceutical pay-for-delay challenges
- Bid-rigging probes
- Kickback, bribery, and corruption cases
- Challenges to state aid and other subsidies
- LITIGATION
- Antitrust class actions
- Price-fixing cases
- Illegal monopoly suits
- PROFILES
- Personnel moves
- Profiles of competition practices
Readership
- Antitrust and competition lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals